Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Daniel J Baker

3PUBLICATIONS
15CO-AUTHORS
Metabolic medicineReaction engineering (excl. nuclear reactions)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Dec 15, 2025
Reductive death is averted by an ancient metabolic switch.

Fasih M Ahsan, Jen F Rotti, Armen I Yerevanian

|May 05, 2025
Quadruple adenine base-edited allogeneic CAR T cells outperform CRISPR/Cas9 nuclease-engineered T cells.

Nils W Engel, Israel Steinfeld, Daniel Ryan

|Jul 26, 2023
CAR T therapy beyond cancer: the evolution of a living drug.

Daniel J Baker, Zoltan Arany, Joseph A Baur

Pageof 1

Frequent Collaborators

2 joint publications

Carl H June

1 joint publications

Zoltan Arany

1 joint publications

Joseph A Baur

1 joint publications

Jonathan A Epstein

1 joint publications

Philipp C Rommel

1 joint publications

Fasih M Ahsan

1 joint publications

Jen F Rotti

1 joint publications

Armen I Yerevanian

1 joint publications

Sinclair W Emans

1 joint publications

Nicole L Stuhr

Frequent Collaborators

2 joint publications

Carl H June

1 joint publications

Zoltan Arany

1 joint publications

Joseph A Baur

1 joint publications

Jonathan A Epstein

Top Related Videos

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
12:55

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis

Published on : Feb 16, 2015

18.5K
Production of Human CRISPR-Engineered CAR-T Cells
06:33

Production of Human CRISPR-Engineered CAR-T Cells

Published on : Mar 15, 2021

12.6K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

653
See more related videos

Top Related Videos

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
12:55

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis

Published on : Feb 16, 2015

18.5K
Production of Human CRISPR-Engineered CAR-T Cells
06:33

Production of Human CRISPR-Engineered CAR-T Cells

Published on : Mar 15, 2021

12.6K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

653
See more related videos